US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

93.07

-0.5740-0.61%

Volume:3K

Turnover:285.49K

Market Cap:403.91M

PE:51.90

High:93.14

Open:92.72

Low:92.62

Close:93.64

52wk High:98.82

52wk Low:67.69

Shares:4.34M

Float Shares:4.34M

Volume Ratio:0.52

T/O Rate:0.07%

Dividend:1.55

Dividend Rate:1.66%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.63

PE(LYR):4.99

Loading ...

Overview Company News Filings

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Biogen, Eisai announce positive recommendation for Leqembi in Canada

Eisai: Canada's Drug Agency Issues Final Positive Recommendation for Leqembi Reimbursement in Early Alzheimer's Disease

THOMSON REUTERS

Alnylam's Latest Data Strengthen Outlook for Nucresiran, TRITON-CM, Oppenheimer Says

MT Newswires Live

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-31

Political and General News Events from August 31

Zenas BioPharma Highlights FDA Review Acceptance for Obexelimab IgG4-RD Filing in Corporate Presentation

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live

Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Alnylam Pharma (ALNY)

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS

Alnylam announces new data at ESC Congress on AMVUTTRA

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

Alnylam, Ionis Fall as Heart-Drug Data Raise Doubts over Combination Treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/PBE/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":93.066,"timestamp":1789490488361,"preClose":93.64,"halted":0,"volume":3076,"delay":0,"changeRate":-0.006129859034600577,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"Trading","change":-0.574,"latestTime":"09-15 12:43:26 EDT","open":92.72,"high":93.14,"low":92.62,"amount":285486.11308,"amplitude":0.005553,"askPrice":93.54,"askSize":400,"bidPrice":93.34,"bidSize":700,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":93.64,"sharesOutstanding":3180000,"nav":92.8444,"aum":404801584,"dividendRate":0.016602,"bidAskSpread":0.002045,"postHourTrading":{"tag":"盘后","latestPrice":93.64,"preClose":93.64,"latestTime":"19:30 EDT","volume":11,"amount":1030.34,"timestamp":1789428602593,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.520129,"impliedVol":0.1831,"impliedVolPercentile":0.4263},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.520129,"shares":4340000,"dividePrice":1.5451,"high":93.14,"amplitude":0.005553,"preClose":93.64,"low":92.62,"week52Low":67.69,"pbRate":"1.63","psRate":"235.29","week52High":98.82,"institutionHeld":0.2552,"latestPrice":93.066,"committee":0.272727,"eps":1.793292,"divideRate":0.016602,"volume":3076,"delay":0,"ttmEps":1.793292,"open":92.72,"prevYearClose":82.15,"prevWeekClose":92.91,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":94.89,"twentyDayClose":94.7167,"sixtyDayClose":84.6404},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664838493","title":"Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838493","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838493?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:20","pubTimestamp":1788229256,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals has delivered strong long term gains over the past five years, yet current valuation checks suggest the stock now looks closer to fairly priced than clearly cheap. For investors, the question is how that past share price performance lines up with what the broader valuation signals are saying today.\n\nThe stock has returned 174.9% over five years, which puts extra focus on whether recent strength already reflects much of the good news in the story.\nFuture growth in cash...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VERX","IE00B2B36J28.USD","BK4588","IE00BJJMRZ35.SGD","VRTX","GNMX","PBE","LU0289739699.SGD","LU1035775433.USD","SG9999001176.USD","LU1674673691.USD","IE0009355771.USD","LU2362540622.SGD","LU2089984988.USD","LU2324357040.USD","LU0109394709.USD","IE0002141913.USD","TACU","LU0234570918.USD","IE00BZ9MQY76.HKD","TBXU","LU1093756168.USD","IBB","LU2417539215.USD","TSPA","BK4139","LU1778281490.HKD","BK4532","IE00B19Z3B42.SGD","SGXZ57979304.SGD","LU1430594728.SGD","LU1559883803.SGD","BIB","LU1674673428.USD","LU1815336091.USD","LU1069344957.HKD","IE00B19Z9Z06.USD","LU0061475181.USD","SG9999001176.SGD","IBBQ","CDIG","LU0432979614.USD","IDNA","IE00B19Z3581.USD","LU0079474960.USD","LU0566484027.USD","BK4585","LU0823416689.USD","BBH","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664925888","title":"Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2664925888","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664925888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:53","pubTimestamp":1788205998,"startTime":"0","endTime":"0","summary":"UPDATE 2-Trump administration announces drug pricing deals with CSL, Astellas and othersWASHINGTON, Aug 31 (Reuters)-U.S. President Donald Trump announced a new round of drug-pricing agreements with i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","CSL.AU","IE00BJT1NW94.SGD","BK4505","LU1057294990.SGD","TBXU","OZEM","LU0321505439.SGD","300485","LU0225284248.USD","BK0028","AMGN","688235","PFE","SG9999002224.SGD","LU0868494617.USD","LU0889565916.HKD","LU1883839398.USD","IE0002141913.USD","BK0012","BIB","IE00BFTCPJ56.SGD","IONS","BK0046","IE00BJJMRZ35.SGD","LU0306806265.USD","LU1983299246.USD","LU0320765992.SGD","IE00BLSP4452.SGD","BBH","PJP","BK4566","SG9999001176.SGD","BK4007","IE00B3T34201.USD","SGXZ57979304.SGD","LU2468319806.SGD","BK4534","LU0109394709.USD","IE0002270589.USD","IE00BLSP4239.USD","IBBQ","BK4550","IBB","IE00BBT3K403.USD","LU2242646821.SGD","PBE","BBIO","LU1894683348.USD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000087","title":"Biogen, Eisai announce positive recommendation for Leqembi in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000087","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000087?lang=en_us&edition=fundamental","pubTime":"2026-09-01 02:10","pubTimestamp":1788199810,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen Canada (BIIB) announced receipt of the Canada’s Drug Agency’ final positive recommendation supporting public reimbursement...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biogen-eisai-announce-positive-recommendation-for-leqembi-in-canada-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biogen-eisai-announce-positive-recommendation-for-leqembi-in-canada-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234570918.USD","BK4533","BK4585","ESAIY","IE00B894F039.SGD","LU0109394709.USD","PBE","IE00B19Z9P08.USD","LU0889565916.HKD","LU0320765992.SGD","BK4139","BK4588","BIIB","BMED","IE00B19Z9Z06.USD","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664300705","title":"Eisai: Canada's Drug Agency Issues Final Positive Recommendation for Leqembi Reimbursement in Early Alzheimer's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2664300705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664300705?lang=en_us&edition=fundamental","pubTime":"2026-09-01 02:07","pubTimestamp":1788199651,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S0DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4532","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","PBE","BMED","LU0234570918.USD","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","BK4139","IE00B894F039.SGD","BK4585","BK4533","BIIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663002891","title":"Alnylam's Latest Data Strengthen Outlook for Nucresiran, TRITON-CM, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2663002891","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663002891?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:40","pubTimestamp":1788190844,"startTime":"0","endTime":"0","summary":"Alnylam Pharmaceuticals' (ALNY) latest data strengthen the case for Nucresiran and TRITON-CM success, while supporting near-term upside for the stock, Oppenheimer said in a note Sunday.The analysts sa","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU0882574055.USD","BK4548","LU0114720955.EUR","PBE","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","BK4139","ALNY","BK4585","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663321004","title":"NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-31","url":"https://stock-news.laohu8.com/highlight/detail?id=2663321004","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663321004?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:01","pubTimestamp":1788188477,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-08-31Nasdaq 100.NDXTop PerformersPercent ChangeTesla IncTSLA.OQ+4.6%CrowdStrike Holdings, Inc.CRWD.OQ+3.8%QUALCOMM Incorp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL8N44S1CE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","LU0114720955.EUR","LU0466842654.USD","LU1064131342.USD","QQQ","HK0000914686.HKD","QID","LU1852331112.SGD","TLA","IE0034235303.USD","GUNZ","LU1674673428.USD","TSLP","LU1261432733.SGD","LTL","09366","TSDD","LU2357305700.SGD","TSLL","LU1235294995.USD","SMOG","QCMU","LU1804176565.USD","BK4554","IE0004445239.USD","TESL","LU2471134796.USD","LU1435385759.SGD","SG9999000418.SGD","BK4023","LU1923622614.USD","LU1989773731.SGD","BK4097","LU2249611893.SGD","LU2286300806.USD","IE00B19Z9P08.USD","BK4099","LU0345769128.USD","LU1720051017.SGD","LU2211815571.USD","TSLZ","LU1496350502.SGD","GB00BDT5M118.USD","LU0081259029.USD","QQQM","LU2125909916.SGD","LU1823568750.SGD","LU0316494557.USD","NERD","LU2247934214.USD","BK4543","IE00B19Z8X17.USD","LU0963586101.USD","QCML","LU1778281490.HKD","TSLS","LU0079474960.USD","LU0708995401.HKD","LU0061475181.USD","BK4548","HAKY","LU2023250504.SGD","LU2756315318.SGD","TSLT","CLOD","QQQX","TSLI","LU1691799644.USD","SNXX","LU1366192091.USD","PBE","LU1551013425.SGD","LU1069344957.HKD","SHOP","LU1861558580.USD","NJUL","LU1244550494.USD","LU1992135399.USD","SQQQ","LU2264538146.SGD","TSLO","LU1066051811.HKD","COWG","TMSL","XLC","LU0345769631.USD","09834","BK4512","BK4532","LU0823421416.USD","LU2250418816.HKD","SCHM","LU1035775433.USD","TSLY","LU2125909759.SGD","DISK","07266","IGV","LU1232071149.USD","LU1066053197.SGD","LU1145028129.USD","IE00B1BXHZ80.USD","LU1244550221.USD","IE00BK4W5L77.USD","TSII","LU2543165471.USD","BK4588","EYES","LU2517655028.SGD","LU2125909247.SGD","LU0672654240.SGD","SNDU","LU2168564222.USD","SNDQ","CRWL","LU0077335932.USD","SG9999002224.SGD","BK4579","BK4575","LU0820561909.HKD","LU2471134952.CNY","SNDC","TSYY",".IXIC","LU0320765992.SGD","LU0820561818.USD","LU1084165304.USD","FDRV","LU0964807845.USD","07522","BK4592","FCUS","GPIQ","LU2168564495.EUR","QMAR","BK4187","SG9999002232.USD","TSLG","WCBR","CNAV","BK4598","LU0689472784.USD","LU1992135472.HKD","IE00B19Z9505.USD","WATS","LU1914381329.SGD","TSL","SNDG","SG9999015945.SGD","SG9999001424.SGD","NOCT","BK4534","WDAY","LU1917777945.USD","TQQQ","BK4528","LU0348723411.USD","LU2213496289.HKD","TQQY","IE00B19Z8W00.USD","WANT","LU1951198990.SGD","NDX","BK4574","LU1988902786.USD","IE00BZ9MQY76.HKD","BK4550","LU0056508442.USD","07568","SPAM","LU0234570918.USD","LU2023250330.USD","IE00BJLML261.HKD","LU2290526834.HKD","LU2471134523.USD","LU0234572021.USD","LU1066051498.USD","LU2272731600.USD","LU0109394709.USD","LU0823414478.USD","IE00B19Z9Z06.USD","LU2756315664.SGD","LU1839511570.USD","BK4170","BK4612","LU0868494708.USD","BK4139","LU1861559042.SGD","LU0320765059.SGD","LU2896262040.SGD","SNDK","LU0323591593.USD","LIT","LU1674673691.USD","HK0000914660.USD","QQQG","LU2265009873.SGD","LU1169590202.USD","LU1935042991.SGD","LU0109391861.USD","LU1923622291.USD","CIBR","LU0390134368.USD","LU2063271972.USD",".HXC","LU0345770308.USD","LU1712237335.SGD","LU0345770993.USD","SG9999015978.USD","LU0943347566.SGD","BK4566","LU0820562030.AUD","LU0640476718.USD","NJAN","LU2272731782.SGD","LU2517655291.USD","LU1169589451.USD","LU2471134879.HKD","LU0942090050.USD","LU2403377893.USD","QLD","LU1244550577.SGD","LU2326559502.SGD","IE00B1XK9C88.USD","LU2360107168.USD","LU0889565916.HKD","IE00BGHQDM52.EUR","ELOL","LU0107464264.USD","SHPD","LU2462157665.USD","LU2602419157.SGD","07366","LU0823421333.USD","LU2125909593.SGD","LU2087621335.USD","OPTZ","LU2168563687.JPY","BK4560","LU1551013342.USD","TSLA","BUG","BNGE","ALNY","BK4605","LU2517655374.HKD","IE00BSNM7G36.USD","BK4516","LU0210536198.USD","LU2106854487.HKD","IE00BWXC8680.SGD","LU1066051225.USD","LU0198837287.USD","NAPR","CRSH","SCHA","QDEC","PSQ","LU0054578231.USD","LU2750360641.GBP","LU2433249047.HKD","BK4585","LU0082616367.USD","LU2750360997.AUD","BK4524","TSLW","QCMD","LU1267930730.SGD","TTWO","07766","LU1046421795.USD","LU0097036916.USD","LU2168564149.EUR","QCOM","IE00B894F039.SGD","TESC","BK4141","BK4551","BK4573","LU0823411888.USD","LU1861215975.USD","TSLQ","07261","LU1951200564.SGD","BK4555","03455","LU0719512351.SGD","IE00BVYPNQ40.USD","CRWD","LU0314104364.USD","IE00BVYPNP33.GBP","TDV","LU0266013472.USD","09766","RSPC","LU0882574055.USD","LU1935043536.SGD","LU1923623000.USD","02834","XAR","LU1861220033.SGD","LU1629891620.HKD","LU2360106780.USD","SG9999015986.USD","LU2417539215.USD","CRWC","BK4527","LU1119994496.HKD","PSWD","FTXL","IE00B5949003.HKD","03034","LU2456880835.USD","LU2420271590.USD","LU1548497426.USD","BK4085","LU1720051108.HKD","SQCOMmain","LU1323610961.USD","BK4581","09086","BK4515","BK4561","LU1623119135.USD","BK4533","LU1280957306.USD","BK4511","GNMX","FSMD","BK4613","SG9999015952.SGD","LU1429558221.USD","BK4116","IE00BK4W5M84.HKD","LU0053666078.USD","LU0133085943.USD","IDRV","AIPI","AXUP","LU1989763005.USD","BK4604","SHPU","LU2236285917.USD","IE0009356076.USD","LU2108987350.USD","ESPO","TEST","TSLR","HERO","03086","LU2168564065.EUR","LU1974910355.USD","PTF","STSLAmain","AXON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663005748","title":"Political and General News Events from August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663005748?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182117,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 31Aug 31 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","BK4599","LU1983299246.USD","PBE","IE00BFTCPJ56.SGD","LU0868494617.USD","BK4581","IE0002141913.USD","TBXU","BIB","AMGN","LU1061106388.HKD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU2468319806.SGD","IBBQ","BK4588","LU0320765992.SGD","PJP","BBH","IE00BJJMRZ35.SGD","LU1571399168.USD","SG9999001440.SGD","LU2242646821.SGD","BK4139","IE00B2B36J28.USD","LU2089984988.USD","LU2242652126.USD","BK4534","LU0058720904.USD","BK4585","BK4566","IBB","IE00BJT1NW94.SGD","LU0889565916.HKD","BK4533","LU0122379950.USD","LU2112291526.USD","LU0109394709.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663400588","title":"Zenas BioPharma Highlights FDA Review Acceptance for Obexelimab IgG4-RD Filing in Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2663400588","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663400588?lang=en_us&edition=fundamental","pubTime":"2026-08-31 20:51","pubTimestamp":1788180706,"startTime":"0","endTime":"0","summary":"Zenas BioPharma highlights FDA review acceptance for obexelimab IgG4-RD filing in corporate presentationZenas Biopharma outlined plans to seek US approval for obexelimab in IgG4-related disease, with ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLbbwccJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZBIO","RPRX","PBE","IHE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663008638","title":"Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663008638","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663008638?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:50","pubTimestamp":1788177029,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNT...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alnylam-pharma-alny-lakefront-biotherapeutics-lkft-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alnylam-pharma-alny-lakefront-biotherapeutics-lkft-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LU0128526141.USD","LU0109394709.USD","LU0114720955.EUR","GNMX","LU0320765992.SGD","BNTX","BK4535","BK4581","BK4548","PBE","BK4568","LU0889565916.HKD","BK4551","HCSG","LKFT","LU0882574055.USD","LU0029874061.USD","BK4585","ALNY","XBI","BK4139","BK4588","XLV","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071381","title":"Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071381?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169915,"startTime":"0","endTime":"0","summary":"Amgen  said Monday that its cholesterol-lowering drug Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke.The findings came from a pre-specified analysis of the phase 3 VESALIUS-CV trial involving more than 12,000 patients and were presented at the European Society of Cardiology Congress 2026 in Munich, it said.Amgen said Repatha reduced both overall and cardiovascular deaths when added to statins or other LDL-C-lowering treatments. The mortality benefit emerged after about 1.5 years and continued through a median follow-up of 4.6 years, it added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","LU1023059063.AUD","LU2112291526.USD","LU0889565916.HKD","LU2242646821.SGD","BBH","IE00BFTCPJ56.SGD","BK4581","LU1057294990.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU2242652126.USD","PJP","BIB","LU2089984988.USD","LU0320765992.SGD","LU1983299246.USD","IE0002141913.USD","BK4599","BK4588","BK4534","IBB","BK4139","LU0058720904.USD","IE00B2B36J28.USD","PBE","BK4585","SG9999001440.SGD","IBBQ","LU0868494617.USD","BK4533","LU0289739699.SGD","IE0009355771.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU0122379950.USD","BK4566","AMGN","LU2468319806.SGD","TBXU","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079169","title":"Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Alnylam Pharma (ALNY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079169","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663079169?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:30","pubTimestamp":1788168608,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX) and Alnylam Pharma (ALNY) wi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-boston-scientific-bsx-alnylam-pharma-alny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-boston-scientific-bsx-alnylam-pharma-alny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1989772840.SGD","IE0002141913.USD","BK4139","GNMX","LU1057294990.SGD","XLV","LU1989764748.USD","LU1718418525.SGD","LU0077335932.USD","LU1989764664.SGD","LU1791710400.SGD","BK4548","LU2112291526.USD","LU2506952170.USD","LU1804176565.USD","XBI","IE00BFTCPJ56.SGD","LU1720051108.HKD","LU0320765992.SGD","LU0353189763.USD","IE00BJJMRZ35.SGD","LU0128526141.USD","LU0138981039.USD","LU0048584097.USD","ALNY","LABU","LU0345769631.USD","LU2491050071.SGD","BK4504","HCSG","LU0889565916.HKD","BSX","LU0251132253.USD","BK4585","LU2362540622.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","LU2242649171.HKD","LU0267386448.USD","LU1720051017.SGD","LU2506951958.HKD","BK4581","LU0114720955.EUR","LU0266013472.USD","LU0225283273.USD","LU2244417387.USD","LU2362541513.USD","PBE","LU1153585028.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663249076","title":"Amgen Repatha reduces risk of death in high-risk adults for first heart attack","url":"https://stock-news.laohu8.com/highlight/detail?id=2663249076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663249076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167413,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced new findings showing Repatha reduced the risk of death in high-risk adults without a prior heart attack or stroke when added...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","BIB","IE0009355771.USD","LU0122379950.USD","LU2242646821.SGD","BK4588","LU2089984988.USD","IBB","LU0320765992.SGD","AMGN","PJP","IE00BFTCPJ56.SGD","LU1061106388.HKD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","PBE","BK4533","LU0109394709.USD","BK4599","BBH","LU2468319806.SGD","BK4139","BK4534","BK4581","IE00BJT1NW94.SGD","LU1983299246.USD","BK4566","LU0868494617.USD","LU0889565916.HKD","LU2242652126.USD","BK4585","LU0058720904.USD","LU2112291526.USD","TBXU","LU1571399168.USD","IE0002141913.USD","LU0289739699.SGD","LU1023059063.AUD","LU1057294990.SGD","SG9999001440.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663202044","title":"Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=2663202044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663202044?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:18","pubTimestamp":1788160736,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA6XK0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1061106388.HKD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU2242652126.USD","BK4588","BK4139","IE0009355771.USD","AMGN","IE00BJT1NW94.SGD","LU1983299246.USD","IE00B2B36J28.USD","BBH","LU2242646821.SGD","LU0058720904.USD","IE00B4R5TH58.HKD","PBE","TBXU","IBBQ","LU1057294990.SGD","IE0002141913.USD","SG9999001440.SGD","LU1571399168.USD","LU2089984988.USD","BK4534","LU1023059063.AUD","IBB","LU0122379950.USD","BK4533","BK4585","BK4581","PJP","LU0320765992.SGD","BK4566","LU0889565916.HKD","BK4599","LU0109394709.USD","LU0289739699.SGD","LU0868494617.USD","LU2468319806.SGD","BIB","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663047585","title":"Alnylam announces new data at ESC Congress on AMVUTTRA","url":"https://stock-news.laohu8.com/highlight/detail?id=2663047585","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663047585?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:20","pubTimestamp":1788121206,"startTime":"0","endTime":"0","summary":"Alnylam (ALNY) Pharmaceuticals announced new data at the European Society of Cardiology, ESC, Congress 2026 demonstrating the strength of RNAi-powe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alnylam-announces-new-data-at-esc-congress-on-amvuttra-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alnylam-announces-new-data-at-esc-congress-on-amvuttra-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4548","BK4588","LU0109394709.USD","EPV","LU0882574055.USD","LU0114720955.EUR","LU0320765992.SGD","PBE","BK4585","GNMX","ALNY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015099","title":"Crinetics Shareholders Approve Vertex Acquisition at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015099","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015099?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:33","pubTimestamp":1787952818,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals ( ($CRNX) ) has provided an update. On August 28, 2026, Crinetics Pharmaceuticals shareholders held a special meeting at ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0256863811.USD","LU2324357040.USD","LU0757428866.USD","LU1778281490.HKD","LU0289739699.SGD","GNMX","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","LU2417539215.USD","LU0432979614.USD","IBBQ","VERX","BIB","BK4585","LU0061475181.USD","IE0002141913.USD","IE0009355771.USD","IE00B19Z3581.USD","IE00BZ9MQY76.HKD","LU1674673428.USD","VRTX","BK4532","IE00BJJMRZ35.SGD","LU2462157665.USD","TBXU","LU1069344957.HKD","LU1815336091.USD","IDNA","BK4023","LU0823416689.USD","LU2236285917.USD","PBE","LU0566484027.USD","LU0079474960.USD","IBB","BK4533","LU1674673691.USD","BBH","IE00B894F039.SGD","LU1430594728.SGD","LU1093756168.USD","IE00BFTCPJ56.SGD","IE00B19Z9P08.USD","LU0320765992.SGD","LU2468319806.SGD","LU0234570918.USD","BK4567","SG9999001176.SGD","LU2362540622.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663613015","title":"Biogen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663613015","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663613015?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:57","pubTimestamp":1787950620,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  shed 1.35% to $218.50 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.The stock's fall snapped a five-day winning streak.Biogen Inc. closed 1.95% short of its 52-week high of $222.85, which the company achieved on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and AbbVie Inc.  fell 1.03% to $255.48.Trading volume  remained 667,372 below its 50-day average volume of 1.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BIIB","BK4588","IE00B19Z9Z06.USD","BK4532","IE00B19Z9P08.USD","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","PBE","BMED","IE00B894F039.SGD","LU0234570918.USD","BK4139","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015807","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015807","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015807?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:34","pubTimestamp":1787949240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.05% to $432.42 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.This was the stock's fourth consecutive day of losses.Amgen Inc. closed 3.27% below its 52-week high of $447.03, which the company reached on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and AbbVie Inc.  fell 1.03% to $255.48.Trading volume  remained 889,592 below its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","BK4581","PJP","04332","BK4599","LU1571399168.USD","TBXU","IE0002141913.USD","BBH","LU0889565916.HKD","LU2468319806.SGD","IBB","BK4585","PBE","LU0868494617.USD","SG9999001440.SGD","LU1983299246.USD","LU1061106388.HKD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4534","LU2242652126.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","BK4139","LU1023059063.AUD","IE00BJT1NW94.SGD","IBBQ","LU2089984988.USD","BK4588","AMGN","LU0320765992.SGD","BIB","BK4566","LU0122379950.USD","BK4533","LU0058720904.USD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663097210","title":"Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663097210","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663097210?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934634,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. Vertex’s new Phase 1 study, officially titled “A Phase 1, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1430594728.SGD","LU2362540622.SGD","GNMX","IE00BZ9MQY76.HKD","LU1674673428.USD","IE0002270589.USD","IE00B894F039.SGD","BK4139","LU1559883803.SGD","LU1585245621.USD","IE00BJT1NW94.SGD","TBXU","SG9999001176.USD","SG9999001176.SGD","BBH","BIB","LU0566484027.USD","LU2417539215.USD","SGXZ57979304.SGD","LU2362541273.HKD","SG9999013999.USD","VERX","BK4023","LU2089984988.USD","PBE","LU0417517546.SGD","IBBQ","IBB","VRTX","IE00B2B36J28.USD","BK4211","LU0320765992.SGD","LU0823416689.USD","IE0009355771.USD","LU2324357040.USD","ISBC","IE00B19Z3581.USD","BK4585","BK4532","LU0889565916.HKD","LU2237438978.USD","BK4588","LU1815336091.USD","BK4567","LU0058720904.USD","LU1093756325.SGD","IDNA","LU2468319806.SGD","LU2362541513.USD","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663225097","title":"Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663225097","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663225097?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934627,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s latest psoriasis study update spotlights apremilast (AMG 407) for ki...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","LU2112291526.USD","BK4534","LU1057294990.SGD","LU0109394709.USD","BIB","AMGN","BK4211","LU0122379950.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BBH","PBE","BK4581","BK4585","LU0289739699.SGD","LU2242646821.SGD","LU1061106388.HKD","IE0002141913.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","ISBC","LU0320765992.SGD","BK4599","IE00BFTCPJ56.SGD","LU2242652126.USD","BK4139","IE0009355771.USD","LU1571399168.USD","BK4533","TBXU","LU0889565916.HKD","BK4588","SG9999001440.SGD","LU0868494617.USD","LU0058720904.USD","IBB","IBBQ","LU1983299246.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","PJP","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662933990","title":"Alnylam, Ionis Fall as Heart-Drug Data Raise Doubts over Combination Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662933990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662933990?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:43","pubTimestamp":1787921001,"startTime":"0","endTime":"0","summary":"BUZZ-Alnylam, Ionis fall as heart-drug data raise doubts over combination treatment** Shares of Alnylam PharmaceuticalsALNY.Ofall 5.3% to $224, while those of Ionis PharmaceuticalsIONS.Ofall 1.3% to $","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P0XT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","LU0109394709.USD","LU0320765992.SGD","BK4139","ALNY","LU0114720955.EUR","LU0882574055.USD","BK4585","BK4588","BK4548","PBE","LU0889565916.HKD","IONS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}